Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Outi R Saramäki

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|January 2, 2009
Methods for identifying and studying genetic alterations in hormone-dependent cancersOuti R Saramäki, Kati K Waltering, Tapio Visakorpi
International Journal of Cancer|April 28, 2006
Genetic aberrations in prostate cancer by microarray analysisOuti R Saramäki, Kati P Porkka, Robert L Vessella, et al.
BMC Research Notes|August 20, 2014
Mapping of the chromosomal amplification 1p21-22 in bladder cancerMauro Scaravilli, Paola Asero, Teuvo L J Tammela, et al.
International Journal of Cancer|July 24, 2008
Clusterin is epigenetically regulated in prostate cancerHanna E Rauhala, Kati P Porkka, Outi R Saramäki, et al.
Genes, Chromosomes & Cancer|April 1, 2006
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancerOuti R Saramäki, Teuvo L J Tammela, Paula M Martikainen, et al.
The Prostate|September 25, 2014
Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancersAchim Fleischmann, Outi R Saramäki, Inti Zlobec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosisOuti R Saramäki, Anna E Harjula, Paula M Martikainen, et al.
Genes, Chromosomes & Cancer|April 14, 2016
Amplification of the 9p13.3 chromosomal region in prostate cancerLeena Latonen, Katri A Leinonen, Teemu Grönlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2010
Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancerKatri A Leinonen, Teemu T Tolonen, Hazel Bracken, et al.
The American Journal of Pathology|January 12, 2002
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancerKimmo J Savinainen, Outi R Saramäki, Marika J Linja, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|January 2, 2009
Methods for identifying and studying genetic alterations in hormone-dependent cancersOuti R Saramäki, Kati K Waltering, Tapio Visakorpi
International Journal of Cancer|April 28, 2006
Genetic aberrations in prostate cancer by microarray analysisOuti R Saramäki, Kati P Porkka, Robert L Vessella, et al.
BMC Research Notes|August 20, 2014
Mapping of the chromosomal amplification 1p21-22 in bladder cancerMauro Scaravilli, Paola Asero, Teuvo L J Tammela, et al.
International Journal of Cancer|July 24, 2008
Clusterin is epigenetically regulated in prostate cancerHanna E Rauhala, Kati P Porkka, Outi R Saramäki, et al.
Genes, Chromosomes & Cancer|April 1, 2006
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancerOuti R Saramäki, Teuvo L J Tammela, Paula M Martikainen, et al.
The Prostate|September 25, 2014
Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancersAchim Fleischmann, Outi R Saramäki, Inti Zlobec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosisOuti R Saramäki, Anna E Harjula, Paula M Martikainen, et al.
Genes, Chromosomes & Cancer|April 14, 2016
Amplification of the 9p13.3 chromosomal region in prostate cancerLeena Latonen, Katri A Leinonen, Teemu Grönlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2010
Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancerKatri A Leinonen, Teemu T Tolonen, Hazel Bracken, et al.
The American Journal of Pathology|January 12, 2002
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancerKimmo J Savinainen, Outi R Saramäki, Marika J Linja, et al.
Pageof 2